BRITTANY KELLY: Open Payments
NPI 1649858325 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 37 payments from 11 companies in 2025. Trend: 2023 $1,614 · 2024 $454 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $172 |
| Novartis Pharmaceuticals Corporation | 13 | $163 |
| HEARTFLOW, INC. | 1 | $132 |
| Amgen Inc. | 4 | $66 |
| SCPHARMACEUTICALS INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: JARDIANCE, LEQVIO, FFRct, REPATHA, FUROSCIX, SHINGRIX, WAINUA, ELIQUIS.
Industry payments across NE — which companies pay providers there.
